Transforming growth factor-β1 inhibits synthesis of cytokines in endotoxin-stimulated human whole blood

Archives of Surgery

Volumn 131, Issue 12, 1996, Pages 1310-1317

  Karres, Ina ^b   Kremer, Jean Pierre ^b   Steckholzer, Ursula ^a   Kenney, John S ^c   Ertel, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ENDOTOXEMIA; HUMAN; IMMUNE RESPONSE; IMMUNITY; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0029959416     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430240064008     Document Type: Article

References (24)

1. Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J Exp Med. 1989;170:1627-1633.
2. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
3. Ertel W, Kremer JP, Kenney J, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995;85:1341-1347.
4. Randow F, Syrbe U, Meisel C, et al. Mechanism of endotoxin desensitization: involvement of interleukin-10 and transforming growth factor β. J Exp Med. 1995;181:1887-1892.
5. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987;84:5788-5792.
6. Wahl SM, Hunt DA, Wong HL, et al. Transforming growth factor β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol. 1988;140:3026-3032.
7. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987;84:6020-6024.
8. Chantry D, Turner M, Abney E, Feldmann M. Modulation of cytokine production by transforming growth factor-β. J Immunol. 1989;142:4295-4300.
9. Musso T, Espinoza-Delgado I, Pulkki K, Gusella GL, Longo DL, Varesio L. Transforming growth factor β downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood. 1990;76:2466-2469.
10. Ralph P, Nakoinz I, Sampson-Johannes A. Inhibition of the production of interleukin-1 and tumor necrosis factor. Ann N Y Acad Sci. 1991;628:326-336.
11. Turner M, Chantry D, Feldmann M. Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine. 1990;2:211-216.
12. Ayala A, Knotts JK, Ertel W, Perrin MM, Morrison MH, Chaudry IH. Role of interleukin 6 and transforming growth factor-β in the induction of depressed splenocyte responses following sepsis. Arch Surg. 1993;128:89-95.
13. Wilson BM, Severn A, Rapson NT, Chana J, Hopkins P. A convenient human whole blood culture system for studying the regulation of tumor necrosis factor release by bacterial lipopolysaccharide. J Immunol Methods. 1991;139:233-240.
14. DeForge LE, Kenney JS, Jones ML, Warren JS, Remick DG. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. J Immunol. 1992;148:2133-2141.
15. Ertel W, Morrison MH, Ayala A, Chaudry IH. Chloroquine attenuates hemorrtiagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood. 1991;78:1781-1788.
16. Hurme M, Sihvola M, Alitalo K, Keski-Oja J. Transforming growth factor-beta does not alter interleukin-1 expression in cultured human macrophages. J Cell Biochem. 1989;39:467-475.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989;6:36-48.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162: 156-159.
19. Kremer JP, Reisbach G, Nerl C, Dörmer P. B-cell chronic lymphocytic leukemia cells express and release transforming growth faclor-β. Br J Haematol. 1992;80:480-487.
20. Ranges GE, Figari IS, Espevik T, Palladino MA Jr. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor-α. J Exp Med. 1987;166:991-998.
21. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem. 1992;267:23301-23308.
22. Knudsen PJ, Dinarello CA, Strom TB. Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol. 1986;137:3189-3194.
23. Masui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A. 1986;83:2438-2442.
24. Muldoon LL, Rodland KD, Magun BE. Transforming growth factor β modulates epidermal growth-factor-induced phosphoinositide metabolism and intracellular calcium levels. J Biol Chem. 1988;263:5030-5033.